221 related articles for article (PubMed ID: 24998908)
1. Multiple paracrine factors secreted by mesenchymal stem cells contribute to angiogenesis.
Kwon HM; Hur SM; Park KY; Kim CK; Kim YM; Kim HS; Shin HC; Won MH; Ha KS; Kwon YG; Lee DH; Kim YM
Vascul Pharmacol; 2014 Oct; 63(1):19-28. PubMed ID: 24998908
[TBL] [Abstract][Full Text] [Related]
2. Potentiated therapeutic angiogenesis by primed human mesenchymal stem cells in a mouse model of hindlimb ischemia.
Lee EJ; Park HW; Jeon HJ; Kim HS; Chang MS
Regen Med; 2013 May; 8(3):283-93. PubMed ID: 23627823
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic potential of ixmyelocel-T, an expanded autologous multicellular therapy for treatment of ischemic cardiovascular diseases.
Ledford KJ; Murphy N; Zeigler F; Bartel RL; Tubo R
Stem Cell Res Ther; 2015 Mar; 6(1):25. PubMed ID: 25889271
[TBL] [Abstract][Full Text] [Related]
4. Nonendothelial mesenchymal cell-derived MCP-1 is required for FGF-2-mediated therapeutic neovascularization: critical role of the inflammatory/arteriogenic pathway.
Fujii T; Yonemitsu Y; Onimaru M; Tanii M; Nakano T; Egashira K; Takehara T; Inoue M; Hasegawa M; Kuwano H; Sueishi K
Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2483-9. PubMed ID: 16960104
[TBL] [Abstract][Full Text] [Related]
5. Angiogenic effects of human multipotent stromal cell conditioned medium activate the PI3K-Akt pathway in hypoxic endothelial cells to inhibit apoptosis, increase survival, and stimulate angiogenesis.
Hung SC; Pochampally RR; Chen SC; Hsu SC; Prockop DJ
Stem Cells; 2007 Sep; 25(9):2363-70. PubMed ID: 17540857
[TBL] [Abstract][Full Text] [Related]
6. Neurotrophin-3 accelerates wound healing in diabetic mice by promoting a paracrine response in mesenchymal stem cells.
Shen L; Zeng W; Wu YX; Hou CL; Chen W; Yang MC; Li L; Zhang YF; Zhu CH
Cell Transplant; 2013; 22(6):1011-21. PubMed ID: 23043768
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte growth factor stimulated angiogenesis without inflammation: differential actions between hepatocyte growth factor, vascular endothelial growth factor and basic fibroblast growth factor.
Kaga T; Kawano H; Sakaguchi M; Nakazawa T; Taniyama Y; Morishita R
Vascul Pharmacol; 2012 Aug; 57(1):3-9. PubMed ID: 22361334
[TBL] [Abstract][Full Text] [Related]
8. VCAM-1+ placenta chorionic villi-derived mesenchymal stem cells display potent pro-angiogenic activity.
Du W; Li X; Chi Y; Ma F; Li Z; Yang S; Song B; Cui J; Ma T; Li J; Tian J; Yang Z; Feng X; Chen F; Lu S; Liang L; Han ZB; Han ZC
Stem Cell Res Ther; 2016 Apr; 7():49. PubMed ID: 27044487
[TBL] [Abstract][Full Text] [Related]
9. Altered protein secretions during interactions between adipose tissue- or bone marrow-derived stromal cells and inflammatory cells.
Hattori H; Ishihara M
Stem Cell Res Ther; 2015 Apr; 6(1):70. PubMed ID: 25884474
[TBL] [Abstract][Full Text] [Related]
10. Platelet-derived growth factor C promotes revascularization in ischemic limbs of diabetic mice.
Moriya J; Wu X; Zavala-Solorio J; Ross J; Liang XH; Ferrara N
J Vasc Surg; 2014 May; 59(5):1402-9.e1-4. PubMed ID: 23856609
[TBL] [Abstract][Full Text] [Related]
11. Important role of apoptosis signal-regulating kinase 1 in ischemia-induced angiogenesis.
Izumi Y; Kim-Mitsuyama S; Yoshiyama M; Omura T; Shiota M; Matsuzawa A; Yukimura T; Murohara T; Takeya M; Ichijo H; Yoshikawa J; Iwao H
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1877-83. PubMed ID: 15976330
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cell-derived interleukin-6 and vascular endothelial growth factor promote breast cancer cell migration.
De Luca A; Lamura L; Gallo M; Maffia V; Normanno N
J Cell Biochem; 2012 Nov; 113(11):3363-70. PubMed ID: 22644871
[TBL] [Abstract][Full Text] [Related]
13. Macrophages regulate smooth muscle differentiation of mesenchymal stem cells via a prostaglandin F₂α-mediated paracrine mechanism.
Lee MJ; Kim MY; Heo SC; Kwon YW; Kim YM; Do EK; Park JH; Lee JS; Han J; Kim JH
Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2733-40. PubMed ID: 22962328
[TBL] [Abstract][Full Text] [Related]
14. Combination of stromal-derived factor-1alpha and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization.
Yu JX; Huang XF; Lv WM; Ye CS; Peng XZ; Zhang H; Xiao LB; Wang SM
J Vasc Surg; 2009 Sep; 50(3):608-16. PubMed ID: 19595531
[TBL] [Abstract][Full Text] [Related]
15. Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization.
Hiasa K; Ishibashi M; Ohtani K; Inoue S; Zhao Q; Kitamoto S; Sata M; Ichiki T; Takeshita A; Egashira K
Circulation; 2004 May; 109(20):2454-61. PubMed ID: 15148275
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity.
Fujiwara M; Muragaki Y; Ooshima A
Arch Dermatol Res; 2005 Oct; 297(4):161-9. PubMed ID: 16184401
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease.
Taniyama Y; Morishita R; Aoki M; Nakagami H; Yamamoto K; Yamazaki K; Matsumoto K; Nakamura T; Kaneda Y; Ogihara T
Gene Ther; 2001 Feb; 8(3):181-9. PubMed ID: 11313789
[TBL] [Abstract][Full Text] [Related]
18. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms.
Kinnaird T; Stabile E; Burnett MS; Shou M; Lee CW; Barr S; Fuchs S; Epstein SE
Circulation; 2004 Mar; 109(12):1543-9. PubMed ID: 15023891
[TBL] [Abstract][Full Text] [Related]
19. Alginate microencapsulation of human mesenchymal stem cells as a strategy to enhance paracrine-mediated vascular recovery after hindlimb ischaemia.
Landázuri N; Levit RD; Joseph G; Ortega-Legaspi JM; Flores CA; Weiss D; Sambanis A; Weber CJ; Safley SA; Taylor WR
J Tissue Eng Regen Med; 2016 Mar; 10(3):222-32. PubMed ID: 23281223
[TBL] [Abstract][Full Text] [Related]
20. Anti-angiogenic effects of ribonucleic acid interference targeting vascular endothelial growth factor and hypoxia-inducible factor-1alpha.
Forooghian F; Das B
Am J Ophthalmol; 2007 Nov; 144(5):761-8. PubMed ID: 17869204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
